The Current Ratio as of December 2024 (TTM) for Purple Biotech Ltd. (PPBT) is 1.27

According to Purple Biotech Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 1.27. This represents a change of -15.62% compared to the average of 1.51 of the last 4 quarters.

Purple Biotech Ltd. (PPBT) Historical Current Ratio (quarterly & annually)

How has PPBT Current Ratio performed in the past?

The mean historical Current Ratio of Purple Biotech Ltd. over the last ten years is 6.68. The current 1.27 Current Ratio has changed 1.80% with respect to the historical average. Over the past ten years (40 quarters), PPBT's Current Ratio was at its highest in in the September 2020 quarter at 19.14. The Current Ratio was at its lowest in in the September 2015 quarter at 1.16.

Purple Biotech Ltd. (PPBT) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Purple Biotech Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Purple Biotech Ltd. (PPBT) Average Current Ratio

How has PPBT Current Ratio performed in the past?

The current Current Ratio of Purple Biotech Ltd. (PPBT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Purple Biotech Ltd. (PPBT) Current Ratio vs. Peers

How is PPBT’s Current Ratio compared to its peers?

Purple Biotech Ltd.’s Current Ratio is less than Pluri Inc. (5.90), less than BioLineRx Ltd. (1.52), greater than Aridis Pharmaceuticals, Inc. (0.24), less than Enlivex Therapeutics Ltd. (9.71), less than Anebulo Pharmaceuticals, Inc. (3.45), less than PMV Pharmaceuticals, Inc. (13.98), less than Miromatrix Medical Inc. (3.46), greater than ZIVO Bioscience, Inc. (0.17), less than Bionomics Limited (3.30), greater than Bio-Path Holdings, Inc. (0.86), greater than Endonovo Therapeutics, Inc. (0.00), less than Cingulate Inc. (7.35), less than Soleno Therapeutics, Inc. (17.26), less than Cingulate Inc. (0), less than SAB Biotherapeutics, Inc. (7.35), less than Cadrenal Therapeutics, Inc. Common Stock (3.69), less than Monopar Therapeutics Inc. (3.69), less than null (5.41),

Build a custom stock screener for Purple Biotech Ltd. (PPBT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Purple Biotech Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Purple Biotech Ltd. (PPBT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Purple Biotech Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.